Cardiac rescue with enoximone in volume and catecholamine refractory septic shock.
In December 2000 and February 2001, two children with suspected meningococcal disease were admitted to our pediatric intensive unit. Their Glasgow Meningococcal Septicaemia Prognostic score was 12 points. General treatment including antibiotics, steroids in case of meningitis, and fluid replacement, was performed. Despite appropriate volume replacement, intubation and ventilation, noradrenaline and adrenaline continuous infusions < or =1.0 microg/kg/min, and additional bolus infusions, cardiac output deteriorated within minutes in both children. Calcium and bicarbonate were given without sustained effect. Echocardiography demonstrated no pericardial effusion and shortening fraction was <10%. External cardiac massage had to be performed immediately in one case for electromechanical uncoupling. Both patients received a bolus of enoximone 2 mg/kg and 5 mg/kg body weight, respectively, followed by a continuous infusion of 20-23 microg/kg/min. Thereafter, both children had an adequate blood pressure and their shortening fraction increased to >30%. Within minutes, the catecholamine infusion could be reduced in both patients. The children completely recovered from their life-threatening situations. In patients with severe prolonged catecholamine and volume refractory endotoxin shock in Waterhouse-Friderichsen syndrome, even with electromechanical uncoupling and complete myocardial arrest, enoximone can immediately restore myocardial contractility.
Ringe
Hannelore I G
HI
Paediatric Intensive Care Unit, Charité Children's Hospital, Humboldt University Berlin, Berlin, Germany. hannelore.ringe@charite.de
Varnholt
Verena
V
Gaedicke
Gerhard
G
D002303:Cardiac Output, Low / Q000209:etiology* / Q000628:therapy*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D017335:Enoximone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000150:complications*; D010952:Plasma Substitutes / Q000627:therapeutic use; D012772:Shock, Septic / Q000150:complications*; D017211:Treatment Failure
D002316:Cardiotonic Agents; D002395:Catecholamines; D010952:Plasma Substitutes; D017335:Enoximone